0.9631
0.95%
0.0091
Precedente Chiudi:
$0.954
Aprire:
$0.95
Volume 24 ore:
173.70K
Relative Volume:
0.40
Capitalizzazione di mercato:
$28.44M
Reddito:
$69.23M
Utile/perdita netta:
$-33.10M
Rapporto P/E:
-0.8523
EPS:
-1.13
Flusso di cassa netto:
$-39.26M
1 W Prestazione:
+20.01%
1M Prestazione:
-2.72%
6M Prestazione:
-55.82%
1 anno Prestazione:
-32.18%
Neuronetics Inc Stock (STIM) Company Profile
Nome
Neuronetics Inc
Settore
Industria
Telefono
877-600-7555
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Confronta STIM con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
0.9631 | 28.44M | 69.23M | -33.10M | -39.26M | -1.13 |
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-13 | Downgrade | William Blair | Outperform → Mkt Perform |
2021-10-13 | Downgrade | BTIG Research | Buy → Neutral |
2021-10-13 | Downgrade | William Blair | Outperform → Mkt Perform |
2021-01-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2020-02-06 | Iniziato | BTIG Research | Buy |
2018-07-24 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Neuronetics Inc Borsa (STIM) Ultime notizie
Transcranial Magnetic Stimulator Market Overall Study Report - openPR
GSA Capital Partners LLP Purchases 30,837 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Transcranial Magnetic Stimulator Market Future Business - openPR
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics - TipRanks
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval - MSN
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Neuronetics to Present at Piper Sandler Healthcare Conference in December 2024 | STIM Stock News - StockTitan
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MSN
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12% - Simply Wall St
Neuronetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025 - Yahoo Finance
William Blair Decreases Earnings Estimates for Neuronetics - Defense World
Greenbrook TMS Acquisition by Neuronetics Approved - TipRanks
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Neuronetics regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc - GuruFocus.com
Neuronetics Inc. (STIM) Quarterly 10-Q Report - Quartzy
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Earnings call: Neuronetics reports revenue growth amidst strategic shifts By Investing.com - Investing.com Nigeria
Neuronetics regains Nasdaq compliance with bid price - Investing.com
Earnings call: Neuronetics reports revenue growth amidst strategic shifts - Investing.com
Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript - Insider Monkey
Neuronetics announces inducement grant - Medical Buyer
Neuronetics Regains Nasdaq Compliance with Bid Price - TipRanks
Neuronetics stock hits 52-week low at $0.66 amid market challenges - Investing.com Australia
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and Strategic Shifts - GuruFocus.com
Neuronetics, Inc. Holds Special Meeting of Stockholders and Receives Approval for Various ProposalsNeuronetics, Inc. (NASDAQ: STIM) recently conducted a Special Meeting of Stockholders on November 8, 2024, whereby several proposals were put forth fo - Defense World
Neuronetics (NASDAQ: STIM) Announces Key Financial Updates and FDA Clearance for Adolescent Treatment - Defense World
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... - Yahoo Finance
Neuronetics Reports Growth and Strategic Acquisition - TipRanks
CORRECTION-Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - The Manila Times
Neuronetics Q3 Revenue Grows 4%, Margins Surge Despite Widening Losses | STIM Stock | STIM Stock News - StockTitan
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Awards 13,500 RSUs to New Employees in Key Talent Acquisition Move | STIM Stock News - StockTitan
500: Something went wrong - Investing.com India
U.S. Stock market: BTC Digital(+314.68%), BTCS Inc.(+35.64%), Neuronetics(−41.36%) among most volatile stocks during mid day trading - Business Upturn
Neuronetics Inc (STIM) Q3 2024 Earnings: EPS of $(0.44) Misses E - GuruFocus.com
U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn
Neuronetics: Q3 Earnings Snapshot - San Antonio Express-News
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - The Manila Times
Neuronetics Q3 Revenue Grows 4% to $18.5M, Margins Surge Despite Wider Losses | STIM Stock News - StockTitan
Greenbrook TMS Shareholders Approve Neuronetics Acquisition - TipRanks
Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Neuronetics (STIM) Set to Announce Quarterly Earnings on Tuesday - Defense World
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St
Neuronetics Inc Azioni (STIM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Neuronetics Inc Azioni (STIM) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
MACAN WILLIAM ANDREW | EVP, GC, CCO and CS |
Oct 08 '24 |
Sale |
0.82 |
1,541 |
1,264 |
402,792 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):